Is biote Corp. (BTMD) Stock Outpacing Its Medical Peers This Year? [Yahoo! Finance]
Doximity, Inc. Class A (DOCS)
Company Research
Source: Yahoo! Finance
biote Corp. (BTMD) has outperformed its medical peers this year, with a 28.5% return since the start of the calendar year, compared to a 2.4% loss for the average medical stock. The company's strong performance is reflected in its Zacks Rank of #2 (Buy) and a 46.2% increase in its full-year earnings estimate over the past quarter. BTMD is also outperforming its industry, Medical - Products, which has gained 11.4% year-to-date. Another medical stock, Doximity (DOCS), has also outperformed the sector with an 88% return year-to-date and a Zacks Rank #1 (Strong Buy). Generated by Yahoo Finance AI Yahoo Finance used generative AI to summarize key information from this article. Some details may be inaccurate. We take that seriously. Reporting mistakes helps us improve these summaries. Was this helpful? Yes No For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Has biote Corp. (BTMD) been one of
Show less
Read more
Impact Snapshot
Event Time:
DOCS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DOCS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DOCS alerts
High impacting Doximity, Inc. Class A news events
Weekly update
A roundup of the hottest topics
DOCS
News
- Healthcare In 2025: A Year Of Practical AI, Remote Care And Patient-Centered Solutions [Forbes]Forbes
- 4 Healthcare Stocks Rising More Than 50% in 2024 With Room to Grow [Yahoo! Finance]Yahoo! Finance
- Doximity (DOCS) Ascends But Remains Behind Market: Some Facts to Note [Yahoo! Finance]Yahoo! Finance
- Doximity, Inc. (NASDAQ: DOCS) is now covered by analysts at Stephens. They set an "equal weight" rating and a $55.00 price target on the stock.MarketBeat
- DOXIMITY ALERT: Bragar Eagel & Squire, P.C. is Investigating Doximity, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmGlobeNewswire
DOCS
Earnings
- 11/7/24 - Beat
DOCS
Sec Filings
- 11/15/24 - Form 4
- 11/15/24 - Form 4
- 11/14/24 - Form SC
- DOCS's page on the SEC website